Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Latin America
6.2 By Country
7 Industry Opportunities and Challenges
8 Latin America Genomics Market Analysis
8.1 Key Industry Highlights
8.2 Latin America Genomics Historical Market (2019-2025)
8.3 Latin America Genomics Market Forecast (2026-2035)
8.4 Latin America Genomics Market by Product
8.4.1 Consumables
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2019-2025)
8.4.1.3 Forecast Trend (2026-2035)
8.4.2 Systems and Software
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2019-2025)
8.4.2.3 Forecast Trend (2026-2035)
8.4.3 Systems and Software
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2019-2025)
8.4.3.3 Forecast Trend (2026-2035)
8.5 Latin America Genomics Market by Technology
8.5.1 PCR
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2019-2025)
8.5.1.3 Forecast Trend (2026-2035)
8.5.2 Sequencing
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2019-2025)
8.5.2.3 Forecast Trend (2026-2035)
8.5.3 Microarray
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2019-2025)
8.5.3.3 Forecast Trend (2026-2035)
8.5.4 Nucleic Acid Extraction and Purification
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2019-2025)
8.5.4.3 Forecast Trend (2026-2035)
8.5.5 Others
8.6 Latin America Genomics Market by Application
8.6.1 Diagnostics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2019-2025)
8.6.1.3 Forecast Trend (2026-2035)
8.6.2 Drug Discovery and Development
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2019-2025)
8.6.2.3 Forecast Trend (2026-2035)
8.6.3 Precision Medicine
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2019-2025)
8.6.3.3 Forecast Trend (2026-2035)
8.6.4 Agriculture and Animal Research
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2019-2025)
8.6.4.3 Forecast Trend (2026-2035)
8.6.5 Others
8.7 Latin America Genomics Market by Government Institutes
8.7.1 Research Centres and Academic and Government Institutes
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2019-2025)
8.7.1.3 Forecast Trend (2026-2035)
8.7.2 Hospitals and Clinics
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2019-2025)
8.7.2.3 Forecast Trend (2026-2035)
8.7.3 Pharmaceutical and Biotechnology Companies
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2019-2025)
8.7.3.3 Forecast Trend (2026-2035)
8.7.4 Others
8.8 Latin America Genomics Market by Country
8.8.1 Market Share
8.8.1.1 Brazil
8.8.1.2 Argentina
8.8.1.3 Mexico
8.8.1.4 Others
9 Regional Analysis
9.1 Brazil
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Argentina
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
9.3 Mexico
9.3.1 Historical Trend (2019-2025)
9.3.2 Forecast Trend (2026-2035)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Powers
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Key Company Profiles
12.2.1 Gen-t.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Genotyping
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 UNAM - LIIGH
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 TecSalud
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 INDEAR
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Gema Biotech
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments